Education
About Us
Working with TipRanks
Follow Us
David M Goldstein Insider Profile
4 Followers
David M Goldstein, CSO at Principia Biopharma, holds 247.01K shares in Alumis Inc. (Ticker: ALMS), holds 0.00 shares in Principia Biopharma (Ticker: PRNB).
David M Goldstein Principia Biopharma (PRNB)CSO
Principia Biopharma (PRNB)
CSO
Not Ranked
David M Goldstein has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of David M Goldstein's holdings
Insider Roles
CSO
Roles that David M Goldstein holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by David M Goldstein
David M Goldstein's Trading History
Principia Biopharma
Sep 28, 2020
―
Uninformative Sell
3.18M
$0.00
Alumis Inc.
Jul 31, 2025
CSO
Uninformative Buy
―
$1.02M
List of latest transactions for each holding click on a transaction to see David M Goldstein's performance on stock
You May Also Like
David M Goldstein insider profile FAQ
What is the percentage of profitable transactions made by David M Goldstein?
The percentage of profitable transactions made by David M Goldstein is ―.
What is the average return per transaction made by David M Goldstein?
The average return per transaction made by David M Goldstein is ―.
What stocks does David M Goldstein hold?
David M Goldstein holds: PRNB, ALMS stocks.
What was David M Goldstein’s latest transaction?
David M Goldstein latest transaction was an Uninformative Buy of ―.
What was David M Goldstein's most profitable transaction?
David M Goldstein’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is David M Goldstein's role in Principia Biopharma?
David M Goldstein's role in Principia Biopharma is CSO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.